ZS Pharma's (ZSPH) Price Target Raised to $110 at William Blair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ZS Pharma's (ZSPH) Price Target Raised to $83 at BMO
September 11, 2015 8:22 AM EDTBMO Capital maintained an Outperform rating on ZS Pharma (NASDAQ: ZSPH) and raised its price target to $83.00 (from $70.00).
For an analyst ratings summary and ratings history on ZS Pharma click here. For more ratings news on ZS Pharma click here.
Shares of ZS Pharma closed at $74.73 yesterday.
... MoreZS Pharma (ZSPH) to Resume Trading at 5:50 PM
September 10, 2015 5:36 PM EDTZS Pharma (NASDAQ: ZSPH) to Resume Trading at 5:50 PM
... MoreZS Pharma (ZSPH) Participated in Preliminary Discussions with Actelion
September 10, 2015 5:32 PM EDTZS Pharma, Inc. (Nasdaq: ZSPH), today confirmed that it has participated in preliminary discussions with Actelion Ltd. (OTC: ALIOF) regarding a potential strategic transaction. ZS Pharma regularly and routinely explores opportunities with various strategic... More
Actelion Confirms Discussions with ZS Pharma (ZSPH)
September 10, 2015 5:17 PM EDTActelion Ltd confirmed today that it has initiated preliminary discussions with ZS Pharma, Inc. (Nasdaq: ZSPH) without any commitment on either party.
Actelion does not intend to make any further comments at this time.
... MoreZS Pharma (ZSPH) halted with news pending
September 10, 2015 4:32 PM EDTZS Pharma (NASDAQ: ZSPH) trading halted with news pending.
... MoreRelypsa (RLYP) Gains in Sympathy with ZS Pharma (ZSPH)
September 10, 2015 2:39 PM EDTRelypsa (NASDAQ: RLYP) gained in sympathy with ZS Pharma (NASDAQ: ZSPH) after Bloomberg reported Actelion made a preliminary offer to buy the company last month.
Note: Relypsa is seeking regulatory approval of Patiromer FOS for the treatment of... More
ZS Pharma (ZSPH) Halted on LUDP
September 10, 2015 2:25 PM EDTZS Pharma (NASDAQ: ZSPH) Halted on LUDP
... MoreActelion Said to Make Approach for ZS Pharma (ZSPH)
September 10, 2015 2:24 PM EDT(Updated - September 10, 2015 2:30 PM EDT)
Actelion (OTCBB: ACLIOF) said to make approach for ZS Pharma (Nasdaq: ZSPH), according to Bloomberg headlines.
The deal is said to be valued at about $2.5... More
UPDATE: ZS Pharma (ZSPH) Shares Surge; Conference Cancellation Confirmed
September 10, 2015 10:14 AM EDT(Updated - September 10, 2015 1:02 PM EDT)
ZS Pharma (NASDAQ: ZSPH) shares surged Thursday, rising over 15%. The cause of the spike wasn't clear, though unconfirmed market chatter tied move to a potential conference cancellation.
Update:
According to Bloomberg a Citi spokesperson said ZS... More
